Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients-Reference-Cited by-全球学者库

Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients

Published:2014-02-11 Issue:1 Volume:33 Page:9-14
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol Oncol

Author:

Tomita Naoto¹,Kodama Fumio²,Tsuyama Naoko³,Sakata Seiji⁴,Takeuchi Kengo³⁴,Ishibashi Daisuke⁵,Koyama Satoshi⁶,Ishii Yoshimi¹,Yamamoto Wataru²,Takasaki Hirotaka²,Hagihara Maki¹,Kuwabara Hideyuki⁷,Tanaka Masatsugu⁷,Hashimoto Chizuko²,Yamazaki Etsuko¹,Koharazawa Hideyuki⁸,Fujimaki Katsumichi⁹,Sakai Rika²,Fujisawa Shin⁷,Ishigatsubo Yoshiaki¹

Affiliation:

1. Department of Internal Medicine and Clinical Immunology; Yokohama City University Graduate School of Medicine; Yokohama Japan

2. Department of Medical Oncology; Kanagawa Cancer Center; Yokohama Japan

3. Division of Pathology, The Cancer Institute; Japanese Foundation for Cancer Research; Tokyo Japan

4. Pathology Project for Molecular Targets, The Cancer Institute; Japanese Foundation for Cancer Research; Tokyo Japan

5. Department of Hematology; Yokosuka City Hospital; Yokosuka Japan

6. Department of Hematology; Shizuoka Red Cross Hospital; Shizuoka Japan

7. Department of Hematology; Yokohama City University Medical Center; Yokohama Japan

8. Department of Hematology; Yamato Municipal Hospital; Yamato Japan

9. Department of Hematology/Immunology; Fujisawa City Hospital; Fujisawa Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference31 articles.

1. Peripheral T-cell lymphoma;Foss;Blood,2011

2. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project;Weisenburger;Blood,2011

3. Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan;Tokunaga;Blood,2012

4. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project;Federico;J Clin Oncol,2013

5. Comparison of peripheral T-cell lymphomas and diffuse large B-cell lymphoma;Tomita;Cancer,2007

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Astaxanthin protects against pirarubicin-induced H9c2 cardiomyocytes by adjusting microRNA-494-3p-mediated MDM4/p53 signalling pathway;Journal of Pharmacy and Pharmacology;2023-10-13

2. LncRNA Miat knockdown protects against pirarubicin‐induced cardiotoxicity by targeting miRNA‐129‐1‐3p;Environmental Toxicology;2023-07-20

3. MiR‐494‐3p aggravates pirarubicin‐induced cardiomyocyte injury by regulating MDM4/p53 signaling pathway;Environmental Toxicology;2023-07-08

4. Comparison of first‐line treatments of peripheral T‐cell lymphoma according to regimen: A systematic review and meta‐analysis;Hematological Oncology;2021-09-06

5. Comparison of CHOP with THP-COP for peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective analysis using data from the population-based Osaka Cancer Registry;International Journal of Hematology;2021-04-16